
Scribe Therapeutics Inc.
SCTXHealthcare|Biotechnology|US
$15.70
+0.22 (+1.42%)
Ownership Breakdown
10.5%
Float
16.2M
Shares Outstanding
1.7M
Float Shares
Major Holders (10)
Combined: 92.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Aghazadeh Behzad | Partnership | 16.37% | 3,088,888 | Jul 30, 2026 | 13D/G |
| Avoro Capital Advisors LLC | IA, OO | 13.78% | 2,598,973 | Jul 30, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.60% | 1,802,178 | Aug 3, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.60% | 1,802,178 | Aug 3, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.60% | 1,802,178 | Aug 3, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.10% | 1,714,582 | Aug 3, 2026 | 13D/G |
| ELI LILLY & Co | Corporation | 7.30% | 1,388,161 | Jul 30, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 7.20% | 1,348,825 | Jul 29, 2026 | 13D/G |
| Orbimed Capital GP VIII LLC | Other | 7.20% | 1,348,825 | Jul 29, 2026 | 13D/G |
| Avoro Ventures LLC | IA, OO | 2.60% | 489,915 | Jul 30, 2026 | 13D/G |
Insider Trades (63)
Last 4 quarters: 0 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| AH Bio Fund II, L.P. | 10 percent owner | Jul 27, 2026 | BUY | 333,333 | $15.00 | $5.0M | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 27, 2026 | CONVERSION | 2,051,742 | — | — | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 27, 2026 | CONVERSION | 697,650 | — | — | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 27, 2026 | CONVERSION | 4,131,344 | — | — | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 27, 2026 | CONVERSION | 12,150,003 | — | — | Form 4 |
| GORDON CARL L | director | Jul 27, 2026 | BUY | 1,000,000 | $15.00 | $15.0M | Form 4 |
| GORDON CARL L | director | Jul 27, 2026 | CONVERSION | 348,825 | — | — | Form 4 |
| GORDON CARL L | director | Jul 27, 2026 | CONVERSION | 2,065,672 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | BUY | 1,000,000 | $15.00 | $15.0M | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | CONVERSION | 348,825 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 27, 2026 | CONVERSION | 2,065,672 | — | — | Form 4 |
| Doudna Jennifer A | 10 percent owner | Jul 27, 2026 | CONVERSION | 12,511 | — | — | Form 4 |
| Doudna Jennifer A | 10 percent owner | Jul 27, 2026 | CONVERSION | 74,088 | — | — | Form 4 |
| Aghazadeh Behzad | director, 10 percent owner, other: See Remarks | Jul 28, 2026 | BUY | 7,905 | $18.25 | $144.3K | Form 4 |
| Aghazadeh Behzad | director, 10 percent owner, other: See Remarks | Jul 24, 2026 | BUY | 50,000 | $22.31 | $1.1M | Form 4 |
| Aghazadeh Behzad | director, 10 percent owner, other: See Remarks | Jul 24, 2026 | BUY | 2,333,333 | $15.00 | $35.0M | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | AWARD | 19,385 | $15.00 | $290.8K | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | AWARD | 19,385 | $15.00 | $290.8K | Form 4 |
| Staahl Brett | 10 percent owner | Mar 13, 2026 | AWARD | 4,755 | $19.13 | $91.0K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | AWARD | 109,426 | $15.00 | $1.6M | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | AWARD | 109,426 | $15.00 | $1.6M | Form 4 |
| Lucas Svetlana | Chief Business Officer | Mar 13, 2026 | AWARD | 9,547 | $19.13 | $182.6K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | BUY | 3,000 | $15.00 | $45.0K | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | AWARD | 429,599 | $15.00 | $6.4M | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | AWARD | 264,784 | $15.00 | $4.0M | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Mar 13, 2026 | AWARD | 12,969 | $19.13 | $248.1K | Form 4 |
| GORDON CARL L | director | Jul 23, 2026 | AWARD | 14,725 | $15.00 | $220.9K | Form 4 |
| Watson James Dean | director | Jul 23, 2026 | AWARD | 14,725 | $15.00 | $220.9K | Form 4 |
| Bleharski Joshua | director | Jul 23, 2026 | AWARD | 14,725 | $15.00 | $220.9K | Form 4 |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | AWARD | 109,426 | $15.00 | $1.6M | Form 4 |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | AWARD | 109,426 | $15.00 | $1.6M | Form 4 |
| Parrot David | Chief Financial Officer | Mar 13, 2026 | AWARD | 8,909 | $19.13 | $170.4K | Form 4 |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | BUY | 1,333 | $15.00 | $20.0K | Form 4 |
| Aghazadeh Behzad | director, other: See Remarks | Jul 23, 2026 | AWARD | 14,725 | $15.00 | $220.9K | Form 4 |
| ELI LILLY & Co | 10 percent owner | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |
| ORBIMED ADVISORS LLC | director | Jul 23, 2026 | OTHER | 348,825 | — | — | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 23, 2026 | OTHER | 2,051,742 | — | — | Form 4 |
| AH Bio Fund II, L.P. | 10 percent owner | Jul 23, 2026 | OTHER | 697,650 | — | — | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | OTHER | 2,462 | $3.08 | $7.6K | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | OTHER | 17,798 | $6.40 | $113.9K | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | OTHER | 4,755 | $19.13 | $91.0K | Form 4 |
| Staahl Brett | 10 percent owner | Jul 23, 2026 | OTHER | 1,688 | $6.40 | $10.8K | Form 4 |
| Doudna Jennifer A | 10 percent owner | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Doudna Jennifer A | 10 percent owner | Jul 23, 2026 | OTHER | 12,511 | — | — | Form 4 |
| GORDON CARL L | director | Jul 23, 2026 | OTHER | 348,825 | — | — | Form 4 |
| Watson James Dean | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 | |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 34,490 | $2.85 | $98.3K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 13,016 | $3.08 | $40.1K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 21,108 | $6.40 | $135.1K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 13,171 | $6.40 | $84.3K | Form 4 |
| Lucas Svetlana | Chief Business Officer | Jul 23, 2026 | OTHER | 9,547 | $19.13 | $182.6K | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | OTHER | 25,330 | $3.08 | $78.0K | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | OTHER | 101,320 | $6.40 | $648.4K | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | OTHER | 35,462 | $6.40 | $227.0K | Form 4 |
| Oakes Benjamin L. | director, officer, other: President, CEO | Jul 23, 2026 | OTHER | 12,969 | $19.13 | $248.1K | Form 4 |
| Bleharski Joshua | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 | |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | OTHER | 100,462 | $6.40 | $643.0K | Form 4 |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | OTHER | 13,171 | $6.40 | $84.3K | Form 4 |
| Parrot David | Chief Financial Officer | Jul 23, 2026 | OTHER | 8,909 | $19.13 | $170.4K | Form 4 |
| Aghazadeh Behzad | director, other: See Remarks | Jul 23, 2026 | OTHER | 0 | — | — | Form 4 |